Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Boris Chobrutskiy Chobrutskiy
MAPT (Tau) Expression Is a Biomarker for an Increased Rate of Survival for Low‑grade Glioma
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
MAPT (Tau) Expression Is a Biomarker for an Increased Rate of Survival in Pediatric Neuroblastoma
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Radiotherapy for Low-Grade Glioma(Probably Benign-Glioma)
Japanese Journal of Neurosurgery
Surgery
Neurology
Defining an Intermediate-Risk Group for Low-Grade Glioma: A National Cancer Database Analysis
Anticancer Research
Medicine
Cancer Research
Oncology
Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
PROX1 Is a Predictor of Survival for Gliomas WHO Grade II
British Journal of Cancer
Cancer Research
Oncology
AKT2 Expression Is Associated With Glioma Malignant Progression and Required for Cell Survival and Invasion
Oncology Reports
Medicine
Cancer Research
Oncology
Circulating Biomarkers for High-Grade Glioma
Biomarkers in Medicine
Biochemistry
Drug Discovery
Clinical Biochemistry
Association of Carcinoid Tumor and Low Grade Glioma
World Journal of Surgical Oncology
Surgery
Oncology
Quantitative Fluorescence Using 5-Aminolevulinic Acid-Induced Protoporphyrin IX Biomarker as a Surgical Adjunct in Low-Grade Glioma Surgery
Journal of Neurosurgery
Surgery
Neurology